Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Prime Peptides
Los Angeles, California, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Prime Peptides is a supplier of research-grade peptides (purity >99%) for laboratory use in diverse fields including neuroscience, immunology, endocrinology, and metabolic disease. They do not have any of their own candidates in clinical trials and have received FDA warnings regarding the sale of unapproved drug substances for human use[1][3][4][5][7][8].
- Therapeutic areas
- ImmunologyEndocrinologyGastroenterologyNeurologyMetabolic Disorders
- Modalities
- Peptides
- Industry
- Non-Drug Biotech
Beyond the preview
Go deeper on Prime Peptides.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Prime Peptides.